Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thats a lot of insider buying this week.. Wondering what more is to come..
Open now
TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, Frankfurt: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into a sponsored research agreement with University of California, San Francisco ("UCSF") to explore the utility of Bucillamine as a treatment for severe COVID-19. The agreement will support research in the laboratory of Dr. John Fahy to test the efficacy of Bucillamine in pre-clinical models of COVID-19 and to design protocols that test the utility of Bucillamine in human trials.
Was there after-hours trading today? Volume increase by roughly 12K after closing bell, or was it closing a Open order from before the bell?
He did have a time when he said he was "unable to discuss" this topic at the moment, topic of the matter being about Big Pharm companies looking into our sector of Bucillamine. Things look like may be in the works towards potential buyout or partnership. Completed section 1, being 210 patients also sounded promising and moving forward.
This call is not well organized
Looks like only 2 shares were printed AH @ .37C
Something will be announced tomorrow, last day of Q1 & the month.
Second on the list. Updated yesterday.
https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker
.2774 Bid / .70 Ask
UPDATED Clinicaltrials.. Dates pushed back by 1 month
1 additional site added. Huntington Beach, CA
27K in volume..
Completion of Phase 3 study of Bucillamine in Q2, 2021
Updated Powerpoint.. 315,634,551 of Common shares now
Ask jumped to .71 last seconds before AH close on E*Trade
.55 keeps climbing!!
Nice moves..
"It is estimated that over 200 patients will have completed the study for the interim analysis by the end of the second quarter of 2021. The interim analysis will determine the better performing Bucillamine dose arm for the remainder of the trial and future complementary studies evaluating it in more severe cases, thus making Bucillamine a potential treatment option"
Closed today..
https://www.sedar.com/CheckCode.do
who thinks news will actually be released this week? If so, what day do you think it would be?
I feel like we should have the slightest signs of a run up before actually having news released. Mid-week if news comes out this week..
Has this company ever released news over the weekend?
While MF has been with the company?
Wouldn't it be better to Uplist before releasing news? This would allow more people to be able to trade on different platforms, along with AH trading being available. It would also allow bigger players to enter in with positions, as some companies don't hold "pink" or anything under $5 as a core to their portfolio.
Ask jumped to .5757 on Etrade right before it Zeroed out at 5PM Eastern.
GME & AMC are making insane returns in short time,
Chance Revive has a similar run-up once interim results are released. Lots of people will have money to reinvest into other sectors.
26K Pre-market.. Something's brewing..
hahah Ferris.. Must be pretty serious
Any chance there is an announcement tomorrow about the launch of the Psych ETF on any main media station?
Why do you think it will be an AH PR?
Reason why they would complete this deal..
If they would've waited, that would've meant results would've been released, leaked, or positive news to some extent. I say that because a company can't "buy" shares "Knowing" that the stock will rise based on upcoming results.. (Insider information)
Therefore, you take a short term hit by issuing the shares 40 million now and let it ride, even if they waited 2, 3, 4 weeks or however long it would take to get results (assuming they are positive results) they would've issued just a smaller amount of shares at a higher price to raise the money they needed from this deal.
I believe this was done on the intent of the upcoming ETF that is to be launched in early Feb.
Does anyone recall the amount of outstanding shares that were available during the December Powerpoint presentation on RVVTF website?
working now.
RVVTF website is not loading..
ACRS another Arthritis treatment just tripled after positive results..
RVVTF is going to go crazy when positive news gets released..